Sghaier, R.; Perus, M.; Cornebise, C.; Courtaut, F.; Scagliarini, A.; Olmiere, C.; Aires, V.; Hermetet, F.; Delmas, D.
Resvega, a Nutraceutical Preparation, Affects NFκB Pathway and Prolongs the Anti-VEGF Effect of Bevacizumab in Undifferentiated ARPE-19 Retina Cells. Int. J. Mol. Sci. 2022, 23, 11704.
https://doi.org/10.3390/ijms231911704
AMA Style
Sghaier R, Perus M, Cornebise C, Courtaut F, Scagliarini A, Olmiere C, Aires V, Hermetet F, Delmas D.
Resvega, a Nutraceutical Preparation, Affects NFκB Pathway and Prolongs the Anti-VEGF Effect of Bevacizumab in Undifferentiated ARPE-19 Retina Cells. International Journal of Molecular Sciences. 2022; 23(19):11704.
https://doi.org/10.3390/ijms231911704
Chicago/Turabian Style
Sghaier, Randa, Maude Perus, Clarisse Cornebise, Flavie Courtaut, Alessandra Scagliarini, Céline Olmiere, Virginie Aires, François Hermetet, and Dominique Delmas.
2022. "Resvega, a Nutraceutical Preparation, Affects NFκB Pathway and Prolongs the Anti-VEGF Effect of Bevacizumab in Undifferentiated ARPE-19 Retina Cells" International Journal of Molecular Sciences 23, no. 19: 11704.
https://doi.org/10.3390/ijms231911704
APA Style
Sghaier, R., Perus, M., Cornebise, C., Courtaut, F., Scagliarini, A., Olmiere, C., Aires, V., Hermetet, F., & Delmas, D.
(2022). Resvega, a Nutraceutical Preparation, Affects NFκB Pathway and Prolongs the Anti-VEGF Effect of Bevacizumab in Undifferentiated ARPE-19 Retina Cells. International Journal of Molecular Sciences, 23(19), 11704.
https://doi.org/10.3390/ijms231911704
